These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 17581601

  • 1. Lercanidipine, enalapril and their combination in the treatment of elderly hypertensive patients: placebo-controlled, randomized, crossover study with four ABPM.
    Puig JG, Calvo C, Luurila O, Luurila H, Sulosaari S, Strandberg A, Ghezzi C.
    J Hum Hypertens; 2007 Dec; 21(12):917-24. PubMed ID: 17581601
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the antihypertensive effects of the fixed dose combination enalapril 10 mg/nitrendipine 20 mg vs losartan 50 mg/hydrochlorothiazide 12.5 mg, assessed by 24-h ambulatory blood pressure monitoring, in essential hypertensive patients.
    de la Sierra A, Gil-Extremera B, Calvo C, Campo C, García-Puig J, Márquez E, Oliván J, Roca Cusachs A, Sanz de Castro S, Pontes C, Delgadillo J.
    J Hum Hypertens; 2004 Mar; 18(3):215-22. PubMed ID: 14973517
    [Abstract] [Full Text] [Related]

  • 3. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P, Dorigatti F, Mugellini A, Spagnuolo V, Varì N, Ferrara R, Bertocchi F.
    Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
    [Abstract] [Full Text] [Related]

  • 4. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD, Mion D, Rocha JC, Kohlmann O, Gomes MA, Saraiva JF, Amodeo C, Filho BL.
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [Abstract] [Full Text] [Related]

  • 5. A randomized, controlled, multicenter study to compare prazosin GITS with enalapril in hypertensive patients with diabetes mellitus. Bombay Hypertension Study Group.
    Joglekar SJ, Nanivadekar AS.
    J Assoc Physicians India; 1998 Sep; Suppl 1():52-62. PubMed ID: 11233387
    [Abstract] [Full Text] [Related]

  • 6. A randomised, placebo-controlled, double-blind, crossover study of losartan and enalapril in patients with essential hypertension.
    Fagard R, Lijnen P, Pardaens K, Thijs L, Vinck W.
    J Hum Hypertens; 2001 Mar; 15(3):161-7. PubMed ID: 11317199
    [Abstract] [Full Text] [Related]

  • 7. Antihypertensive effects of trandolapril and nitrendipine in the elderly: a controlled trial with special emphasis on time effect profiles.
    Zannad F, Vaur L, Dutrey-Dupagne C, Genes N, Clerson P.
    J Hum Hypertens; 1996 Jan; 10(1):51-5. PubMed ID: 8642191
    [Abstract] [Full Text] [Related]

  • 8. [Ambulatory monitoring of arterial pressure in the treatment of mild-moderate arterial hypertension with lisinopril vs. enalapril].
    Motero Carrasco J.
    Arch Inst Cardiol Mex; 1997 Jan; 67(1):29-37. PubMed ID: 9221708
    [Abstract] [Full Text] [Related]

  • 9. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
    Mallion JM, Chamontin B, Asmar R, De Leeuw PW, O'Brien E, Duprez D, O'Rourke MF, Rahn KH, Romero R, Battegay E, Hitzenberger G, Safar ME, REASON Project.
    Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
    [Abstract] [Full Text] [Related]

  • 10. Ambulatory blood pressure-lowering effects of valsartan and enalapril after a missed dose in previously untreated patients with hypertension: a prospective, randomized, open-label, blinded end-point trial.
    Hermida RC, Ayala DE, Khder Y, Calvo C.
    Clin Ther; 2008 Jan; 30(1):108-20. PubMed ID: 18343247
    [Abstract] [Full Text] [Related]

  • 11. Blood pressure-lowering efficacy of amiloride versus enalapril as add-on drugs in patients with uncontrolled blood pressure receiving hydrochlorothiazide.
    Guerrero P, Fuchs FD, Moreira LM, Martins VM, Bertoluci C, Fuchs SC, Gus M.
    Clin Exp Hypertens; 2008 Oct; 30(7):553-64. PubMed ID: 18855259
    [Abstract] [Full Text] [Related]

  • 12. A randomized, double-blind, placebo-controlled, parallel-group study to assess the efficacy and safety of dual ACE/NEP inhibitor GW660511X in mild-to-moderate hypertensive patients.
    Johnson AG, Pearce GL, Danoff TM.
    J Hum Hypertens; 2006 Jul; 20(7):496-503. PubMed ID: 16543907
    [Abstract] [Full Text] [Related]

  • 13. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.
    Esnault VL, Brown EA, Apetrei E, Bagon J, Calvo C, DeChatel R, Holdaas H, Krcmery S, Kobalava Z, Amlodipine Versus Enalapril in Renal failure (AVER) Study Group.
    Clin Ther; 2008 Mar; 30(3):482-98. PubMed ID: 18405787
    [Abstract] [Full Text] [Related]

  • 14. A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction.
    Wald DS, Law M, Mills S, Bestwick JP, Morris JK, Wald NJ.
    Clin Ther; 2008 Nov; 30(11):2030-9. PubMed ID: 19108791
    [Abstract] [Full Text] [Related]

  • 15. A multicenter, parallel comparative study of the antihypertensive efficacy of once-daily lisinopril vs enalapril with 24-h ambulatory blood pressure monitoring in essential hypertension.
    Coca A, Sobrino J, Módol J, Soler J, Mínguez A, Plana J, De la Sierra A.
    J Hum Hypertens; 1996 Dec; 10(12):837-41. PubMed ID: 9140792
    [Abstract] [Full Text] [Related]

  • 16. Blood pressure levels, risk factors and antihypertensive treatments: lessons from the SHEAF study.
    Mallion JM, Genès N, Vaur L, Clerson P, Vaïsse B, Bobrie G, Chatellier G.
    J Hum Hypertens; 2001 Dec; 15(12):841-8. PubMed ID: 11773986
    [Abstract] [Full Text] [Related]

  • 17. A double-blind, randomized, comparative study of nitrendipine and enalapril in elderly hypertensive patients.
    Poncelet P, Werquin S, Warembourg A, Ansquer JC, Boussac I, Lekieffre J, Carre A.
    J Cardiovasc Pharmacol; 1991 Dec; 18 Suppl 1():S67-70. PubMed ID: 1723461
    [Abstract] [Full Text] [Related]

  • 18. Felodipine-metoprolol combination tablet: maintained health-related quality of life in the presence of substantial blood pressure reduction.
    Dahlöf B, Degl' Innocenti A, Elmfeldt D, Puig JG, Gundersen T, Hosie J, Januszewicz W, Lindström CJ, Magometschnigg D, Tanser P, Toutouzas P, Waeber B, Wiklund I.
    Am J Hypertens; 2005 Oct; 18(10):1313-9. PubMed ID: 16202854
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of a fixed-dose combination of lercanidipine and enalapril in daily practice. A comparison of office, self-measured and ambulatory blood pressure.
    Scholze J, Bramlage P, Trenkwalder P, Kreutz R.
    Expert Opin Pharmacother; 2011 Dec; 12(18):2771-9. PubMed ID: 21999703
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of low felodipine dose monotherapy in mild-to-moderate hypertension: a comparison between office and ambulatory blood pressure monitoring.
    Podjarny E, Korzets Z, Bernheim J.
    J Hum Hypertens; 1996 Sep; 10 Suppl 3():S153-6. PubMed ID: 8872849
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.